Physician profile
Amir Daniel
NPI 1154313153
$1,206.19
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2021: $509 · 2022: $323 · 2023: $125 · 2024: $32.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $321.29 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $251.55 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.68 | 2021 | |
| Horizon Therapeutics Plc | $125.00 | 2023 | Krystexxa |
| Daiichi Sankyo INC. | $124.89 | 2021 | |
| Aurinia Pharma U.S., INC. | $121.73 | 2021 | |
| Janssen Pharmaceuticals, INC | $92.69 | 2019 | |
| Taiho Oncology, INC. | $32.95 | 2024 | |
| Travere Therapeutics, INC. | $4.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.